These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12981276)

  • 1. Inhibition of complement fixation by certain serums when tested against psittacosis and lymphogranuloma venereum antigens.
    SCHMIDT N; HARDING HB; HEPLER OE; MURMANN E
    J Infect Dis; 1952; 91(2):173-9. PubMed ID: 12981276
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis-lymphogranuloma venereum group.
    HILLEMAN MR; NIGG C
    J Immunol; 1948 Aug; 59(4):349-64. PubMed ID: 18875384
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis lymphogranuloma venereum group.
    HILLEMAN MR; NIGG C
    J Bacteriol; 1947 Jul; 54(1):59. PubMed ID: 20344286
    [No Abstract]   [Full Text] [Related]  

  • 4. Some observations on the antigenic structure of psittacosis and lymphogranuloma venereum viruses. I. Preparation and use in complement fixation tests of antisera from different sources.
    BARWELL CF
    Br J Exp Pathol; 1952 Jun; 33(3):258-67. PubMed ID: 14935091
    [No Abstract]   [Full Text] [Related]  

  • 5. PREPARATION OF A STABLE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM GROUP COMPLEMENT FIXING ANTIGEN.
    MARABLE IW; NADEL MK
    Am J Med Technol; 1964; 30():94-8. PubMed ID: 14128185
    [No Abstract]   [Full Text] [Related]  

  • 6. The Use of Complement-Fixation Tests in the Study and Diagnosis of Viral Diseases in Man and Animals - A Review: Part VII. The Psittacosis-Lymphogranuloma Venereum Group.
    Rice CE
    Can J Comp Med Vet Sci; 1961 Mar; 25(3):74-9. PubMed ID: 17649291
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic studies on the psittacosis-lymphogranuloma venereum group of viruses. II. Characterization of complement-fixing antigens extracted with sodium lauryl sulfate.
    BENEDICT AA; O'BRIEN E
    J Immunol; 1956 Apr; 76(4):293-300. PubMed ID: 13319707
    [No Abstract]   [Full Text] [Related]  

  • 8. TYPE-SPECIFIC ANTIGENS IN THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM GROUP OF ORGANISMS.
    FRASER CE; BERMAN DT
    J Bacteriol; 1965 Apr; 89(4):943-8. PubMed ID: 14276119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The demonstration of substances in human sera which inhibit complement fixation in antigen-antibody systems of lymphogranuloma venereum, psittacosis, mumps, Q fever, and lymphocytic choriomeningitis.
    SCHMIDT NJ; HARDING HB
    J Bacteriol; 1956 Feb; 71(2):217-22. PubMed ID: 13295197
    [No Abstract]   [Full Text] [Related]  

  • 10. The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group.
    HILLEMAN MR; HAIG DA; HELMOLD RJ
    J Immunol; 1951 Jan; 66(1):115-30. PubMed ID: 14814295
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the stability of substances in human sera which are inhibitory in complement-fixing antigen-antibody systems of lymphogranuloma venereum and psittacosis.
    SCHMIDT NJ; HARDING HB
    Q Bull Northwest Univ Med Sch; 1955; 29(3):241-3. PubMed ID: 13273593
    [No Abstract]   [Full Text] [Related]  

  • 12. DIRECT AND INDIRECT FLUORESCENT-ANTIBODY TECHNIQUES FOR THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM-TRACHOMA GROUP OF AGENTS.
    ROSS MR; BORMAN EK
    J Bacteriol; 1963 Apr; 85(4):851-8. PubMed ID: 14044954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients.
    HILLEMAN MR; GREAVES AB; WERNER JH
    J Lab Clin Med; 1958 Jul; 52(1):53-7. PubMed ID: 13549848
    [No Abstract]   [Full Text] [Related]  

  • 14. The antigenic relationship of lymphogranuloma venereum and psittacosis by skin test in humans.
    POLLARD M; WITKA TM
    Tex Rep Biol Med; 1947; 5(3):288-93. PubMed ID: 20269730
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the chemotherapy of viruses in the psittacosis-lymphogranuloma venereum group; effect of certain chemotherapeutic agents on the growth of psittacosis virus (6BC strain) in tissues cultures and eggs.
    EARLY RL; MORGAN HR
    J Immunol; 1946 Jun; 53():151-6. PubMed ID: 20988495
    [No Abstract]   [Full Text] [Related]  

  • 16. The toxins of the psittacosis-lymphogranuloma group of agents; the toxicity of various members of the psittacosis-lymphogranuloma venereum group.
    MANIRE GP; MEYER KF
    J Infect Dis; 1950; 86(3):226-32. PubMed ID: 15415625
    [No Abstract]   [Full Text] [Related]  

  • 17. INFECTIONS BY ORGANISMS OF PSITTACOSIS/LYMPHOGRANULOMA VENEREUM GROUP IN THE WEST OF SCOTLAND.
    GRIST NR; MCLEAN C
    Br Med J; 1964 Jul; 2(5400):21-5. PubMed ID: 14147769
    [No Abstract]   [Full Text] [Related]  

  • 18. The enhancement and properties of the complement-fixing antigens of lymphogranuloma venereum.
    NIGG C; HILLEMAN MR; BOWSER BM
    Fed Proc; 1946; 5(1 Pt 2):251. PubMed ID: 20984592
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the complement fixation reaction in lymphogranuloma venereum.
    WALL MJ; HEYMAN A; BEESON PB
    Am J Syph Gonorrhea Vener Dis; 1947 May; 31(3):289-99. PubMed ID: 20240338
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapeutic effect of chloromycetin on experimental infection with psittacosis and lymphogranuloma venereum viruses.
    SMADEL JE; JACKSON EB
    Fed Proc; 1948 Mar; 7(1 Pt 1):280. PubMed ID: 18916910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.